Racine Ronny R, Manalo Nathan A, Hall Jessica M F, Dibas Adnan, Raffel Glen D, Mummert Mark E
Department of Cell Biology and Immunology, University of North Texas Health Science Center, 3500, Camp Bowie Boulevard, Fort Worth TX 76104, United States.
Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605, United States.
Biochem Biophys Rep. 2016 Apr 1;6:172-178. doi: 10.1016/j.bbrep.2016.03.016. eCollection 2016 Jul.
The purpose of this study was to investigate how CD44 impaired Akt phosphorylation, EGR-1 expression and cell proliferation. E6.1 Jurkat cells, which lack endogenous CD44 expression, were engineered to express CD44. Previously we showed that Akt is hypophosphorylated, EGR-1 expression is reduced and proliferation is impaired in CD44 expressing E6.1 Jurkat cells. The cell cycle was studied using flow cytometry and the role of calcium (Ca) in Akt phosphorylation and EGR-1 expression was investigated using Western blotting. Phosphatase activity was assessed using a commercially available kit. CD44 expressing cells showed disruption at the G to S transition. Chelation of Ca from the culture media impaired Akt phosphorylation and EGR-1 expression in both CD44 expressing cells and the open vector control. Moreover, Ni disrupted cell proliferation in both cell types suggesting Ca import through calcium release activated calcium channels (CRAC). Staining of cells with fura-2 AM showed significantly higher Ca in CD44 expressing cells as compared with the vehicle control. Finally, non-calcium mediated phosphatase activity was significantly greater in CD44 expressing cells. We propose that the enhanced phosphatase activity in the CD44 cells increased the dephosphorylation rate of Akt; at the same time, the increased intracellular concentration of Ca in the CD44 cells ensured that the phosphorylation of Akt remains intact albeit at lower concentrations as compared with the vector control. Reduced Akt phosphorylation resulted in lowered expression of EGR-1 and hence, reduced the cell proliferation rate.
本研究的目的是探究CD44如何损害Akt磷酸化、EGR-1表达和细胞增殖。缺乏内源性CD44表达的E6.1 Jurkat细胞被改造以表达CD44。此前我们发现,在表达CD44的E6.1 Jurkat细胞中,Akt磷酸化不足、EGR-1表达降低且增殖受损。使用流式细胞术研究细胞周期,并使用蛋白质印迹法研究钙(Ca)在Akt磷酸化和EGR-1表达中的作用。使用市售试剂盒评估磷酸酶活性。表达CD44的细胞在G期到S期的转换过程中出现紊乱。从培养基中螯合Ca会损害表达CD44的细胞和开放载体对照中的Akt磷酸化和EGR-1表达。此外,镍破坏了两种细胞类型中的细胞增殖,提示通过钙释放激活钙通道(CRAC)进行钙内流。用fura-2 AM对细胞进行染色显示,与载体对照相比,表达CD44的细胞中的Ca含量显著更高。最后,表达CD44的细胞中,非钙介导的磷酸酶活性显著更高。我们提出,CD44细胞中增强的磷酸酶活性增加了Akt的去磷酸化速率;同时,CD44细胞中细胞内Ca浓度的增加确保了Akt的磷酸化尽管与载体对照相比浓度较低,但仍保持完整。Akt磷酸化降低导致EGR-1表达降低,从而降低了细胞增殖速率。